Lim, R., Li, A., Kusuma, G., Chan, S., McPhee, G., Fitzpatrick, I., . . . James, D. (2019). Enabling clinical trials in an academic GMP setting through use of closed, semi-automated manufacturing of allogeneic amniotic epithelial cells. Cytotherapy (Elsevier Inc.), 21, S37. https://doi.org/10.1016/j.jcyt.2019.03.370
Chicago Style (17th ed.) CitationLim, R., A. Li, G. Kusuma, S. Chan, G. McPhee, I. Fitzpatrick, S. Wilson, and D. James. "Enabling Clinical Trials in an Academic GMP Setting Through Use of Closed, Semi-automated Manufacturing of Allogeneic Amniotic Epithelial Cells." Cytotherapy (Elsevier Inc.) 21 (2019): S37. https://doi.org/10.1016/j.jcyt.2019.03.370.
MLA (9th ed.) CitationLim, R., et al. "Enabling Clinical Trials in an Academic GMP Setting Through Use of Closed, Semi-automated Manufacturing of Allogeneic Amniotic Epithelial Cells." Cytotherapy (Elsevier Inc.), vol. 21, 2019, p. S37, https://doi.org/10.1016/j.jcyt.2019.03.370.